HISCON 2026
Programme timings and presentation titles are subject to change
Day 1 - Tuesday 23 June
| 09:00 - 09:45 | Registration and refreshments | |
| 09:50 - 10:00 |
Welcome and Introduction Jincy Jerry, Director of Infection Prevention and Control, NHS Ayrshire and Arran, UK |
|
| 10:00 - 10:45 |
Prof Michael Klompas, Professor of Medicine and Population Medicine, Harvard Medical School, USA |
|
| Session 1: Year in infection Prevention and Control | ||
| 10:45 - 11:20 |
|
|
| 10:20 - 11:45 | Break, exhibition and poster viewing | |
| Session 2: Clinical trials and research breakthroughs in IPC | ||
| 11:45 - 12:05 |
|
|
| 12:05 - 12:25 |
Ethics & IPC: Balancing Autonomy with Control Measures |
|
| 12:25 - 12:40 |
Panel Discussion |
|
| 12:40 - 13:00 | Sponsored symposium | |
| 13:00 - 14:15 | Lunch, exhibition and poster viewing | |
| Session 3: National and regional insights in IPC | ||
| 14:15 - 15:45 |
Colin Brown, Deputy Director, Clinical and Emerging Infections, UKHSA, UK Eimear Brannigan, Clinical Lead - AMRIC, Health Service Executive, Ireland Other presenters to be announced |
|
| 15:45 - 16:10 | Break, exhibition and poster viewing | |
| Session 4: Advances and findings in Surveillance | ||
|
16:10 - 16:30 |
|
|
|
16:30 - 16:50 |
|
|
|
16:50 - 17:10 |
|
|
| 17:10 - 17:30 |
Panel Discussion What do surveillance insights mean for IPC practice in the next year |
|
| 17:30 - 19:00 |
Drinks reception & poster presentations |
|
Day 2 - Wednesday 24 June
| 09:00 - 09:30 | Registration and refreshments | |
| Session 5: Sustainability | ||
| 09:30 - 10:15 |
|
|
| 10:15 - 10:35 | Presentation to be confirmed | |
| 10:35 - 10:55 | Presentation to be confirmed | |
| 10:55 - 11:20 | Break and refreshments | |
| Session 6: Oral abstract presentations | ||
| 11:20 - 11:50 | Oral presentations form selected abstracts | |
| 11:50 - 12:10 | Sponsored symposium | |
| 12:10 - 13:10 | Lunch | |
| Session 7: AMR and AMS | ||
| 13:10 - 13:30 |
Research trials including vaccines to prevent AMR and AMS |
|
| 13:30 - 13:50 |
How to develop a strategy for AMR and AMS
|
|
| 13:50 - 14:10 |
AMR - Diagnostics |
|
| 14:10 - 14:25 | Panel Q&A | |
| 14:25 - 14:45 | Break | |
|
14:45 - 15:05 |
|
|
|
15:05 - 15:25 |
|
|
|
15:25 - 15:45 |
|
|
|
15:45 - 16:00 |
Panel Q&A | |
| 16:00 | Event close | |
Keynote Presentation | Advancing surveillance of HCAIs: Focus of VAP
Ongoing and upcoming clinical trials in IPC - Global IPC trends and lessons from WHO guidelines
New national initiatives

Wastewater surveillance for developing pathogen forecasting systems
Presentation | Climate Change & Emerging Pathogens (implications to IPC in healthcare) 
Novel Antimicrobial Stewardship Models
AMR in intensive care
AMR data in conflict areas